Click to Share
 

Diagnostic Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By NuvOx Pharma
NuvOx Pharma has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, "B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer".
By NuvOx Pharma
Evan Unger, MD, President and CEO of NuvOx Pharma, a Tucson based biotechnology company, announced that the company has been awarded a grant from the National Cancer Institute to develop an ultrasound contrast agent to diagnose pancreatic cancer.
By CytoTest Inc.
CytoTest Inc., the Uniformed Services University of the Health Sciences (USU), and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) announced today that they signed a Cooperative Research and Development Agreem
By Lee Biosolutions, Inc
Lee Biosolutions, Inc, a manufacturer and global provider of highly purified enzymes and related proteins for the life science, clinical diagnostic and the biotech healthcare industry, is proud to announce the addition of 3 new members to the Board of...
12399251
By Genomic Expression
Morten Middelfart is joining Genomic Expression as Chief Information Officer. He has a background with more than two decades of analyzing Big Data in business.In addition, he is an inventor in his field with seven US patents and 25 patents worldwide
By Q1 Productions
Payer and ACO Organizations to Present Perspectives on ACO Metrics, Goals, and Building Partnerships
By Cambridge Healthtech Institute
Interview with Richard A. White, Ph.D., Director, Global Strategy, Breast and Colon Products, Genomic Health, Inc.
By Q1 Productions
New One-Day Companion Diagnostics Course Added to Meeting Agenda
By Q1 Productions
Helping Regulatory Affairs Executives around the World Remain Current on Evolving Regulatory Guidance within the Device & Diagnostic Industries, from Securing Regulatory Approval to Meeting Post-Market Vigilance Requirements
By Let's Go Learn, Inc.
Let's Go Learn's K-12 Online Personalized Learning Solution Approved
12275760
By Diagnostic Imaging Systems
ULTRA 12040HF is the Highest Powered Veterinary Unit at the Lightest Weight
12268740
By transasia bio-medicals ltd.
Through its world class manufacturing setup and indigenous research, Transasia works towards meeting the diagnostic needs of patients and doctors across the world.
By transasia bio-medicals ltd.
India's leading IVD Company, Transasia Bio-Medicals Ltd. is committed to global healthcare and our efforts are not only restricted to offering world class solutions. We have always strived to contribute to the society in all the ways we can.
By MediPurpose Inc.
POC Diagnostics Manufacturer to Use SurgiLance™ Safety Lancets in Blood Analysis Equipment
By Biofortuna
Biofortuna, a UK based molecular diagnostics company with a proprietary stabilisation technology for molecular reagents, is expanding its custom service and manufacturing business with a £1.3m investment.
By Sedia Biosciences Corp
Strategic China partner to aid in access to new international markets for the company’s epidemiological and diagnostic products.
12136989
By Launch UK
Launch Tech UK are proud to introduce the latest in their long line of diagnostic tools – the X431 Pad. A leap forward in car diagnostic technology, it combines professional diagnostic abilities with lightening quick performance.
12112397
By MN Systems
Valued at $40,000, prize includes PACS solution with cloud offsite storage and diagnostic Web...
By LamdaGen Corporation
Patent for Ultra-Sensitive In-Vitro and POC Diagnostic Technology...
12054586
By Lee Biosolutions, Inc
Lee BioSolutions is a major supplier of critical components for liver function tests and has increased capacity to meet current demand

All Press Releases

By NuvOx Pharma
NuvOx Pharma has been awarded a grant from the National Cancer Institute for $298,820.00 entitled, "B7-H3-Targeted Contrast Agent for Ultrasonic Imaging of Breast Cancer".
By NuvOx Pharma
Evan Unger, MD, President and CEO of NuvOx Pharma, a Tucson based biotechnology company, announced that the company has been awarded a grant from the National Cancer Institute to develop an ultrasound contrast agent to diagnose pancreatic cancer.
By Visiongain
The Molecular Diagnostics (MDx) Market Forecast 2015-2025: Opportunities for Leading Companies The Molecular Diagnostics (MDx)market will reach $10.45bn in 2019 predicts new visiongain report A new report by visiongain predicts that the global Molecular..
By Q1 Productions
Payer Consolidation, Laboratory Payer Audits Among New Discussion Topics
By EUOR HEALTHCARE
Happy Parents Package a one week offer for Senior Citizens Day with 70% savings
By Peptides International
Hepcidin-Murine Compete™ ELISA Kit is available now and other novel hepcidin ELISA kits are in development
By Q1 Productions
Validation Master Plans, Batch Requirements Among New Session Topics
By CytoTest Inc.
CytoTest Inc., the Uniformed Services University of the Health Sciences (USU), and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) announced today that they signed a Cooperative Research and Development Agreem
By Biorex Food Diagnostics
UK based diagnostic manufacturer Biorex Diagnostics has recently launched their own food safety sister company, Biorex Food Diagnostics.
By Lee Biosolutions, Inc
Lee Biosolutions, Inc, a manufacturer and global provider of highly purified enzymes and related proteins for the life science, clinical diagnostic and the biotech healthcare industry, is proud to announce the addition of 3 new members to the Board of...
By Q1 Productions
Session to Address Current FDA Regulatory Landscape and Impact of 3D Printing Strategies for Protecting Intellectual Property
By Q1 Productions
New UDI Regulations, Global Labeling Requirements Among Discussion Topics at Second Semi-Annual Meeting
By Q1 Productions
Building Sales Strategy, Evolving Technology, Selling in Bundled Markets Among New Topics Up for Discussion
By Q1 Productions
Emerging Technology, Quantifying Training Success Among Discussion Topics
12399251
By Genomic Expression
Morten Middelfart is joining Genomic Expression as Chief Information Officer. He has a background with more than two decades of analyzing Big Data in business.In addition, he is an inventor in his field with seven US patents and 25 patents worldwide
By Q1 Productions
More Than a Dozen In-House Counsel to Offer Perspective During Sessions, Case Studies
By Q1 Productions
Payer and ACO Organizations to Present Perspectives on ACO Metrics, Goals, and Building Partnerships
By BBI Solutions
BBI Solutions (BBI), a world leader in purified human antigen manufacture has launched a fully validated recombinant Cystatin C to the IVD market.
By Cambridge Healthtech Institute
Interview with Richard A. White, Ph.D., Director, Global Strategy, Breast and Colon Products, Genomic Health, Inc.
By Q1 Productions
New One-Day Companion Diagnostics Course Added to Meeting Agenda
By File Management Solutions
Are you happy that your data management processes, systems and resources are fit for purpose?:
By Q1 Productions
Helping Regulatory Affairs Executives around the World Remain Current on Evolving Regulatory Guidance within the Device & Diagnostic Industries, from Securing Regulatory Approval to Meeting Post-Market Vigilance Requirements
By Let's Go Learn, Inc.
Let's Go Learn's K-12 Online Personalized Learning Solution Approved
12275760
By Diagnostic Imaging Systems
ULTRA 12040HF is the Highest Powered Veterinary Unit at the Lightest Weight
12268740
By transasia bio-medicals ltd.
Through its world class manufacturing setup and indigenous research, Transasia works towards meeting the diagnostic needs of patients and doctors across the world.
By transasia bio-medicals ltd.
India's leading IVD Company, Transasia Bio-Medicals Ltd. is committed to global healthcare and our efforts are not only restricted to offering world class solutions. We have always strived to contribute to the society in all the ways we can.
By MediPurpose Inc.
POC Diagnostics Manufacturer to Use SurgiLance™ Safety Lancets in Blood Analysis Equipment
By transasia bio-medicals ltd.
ERBA Diagnostics Mannheim now offers its world class solutions to the Middle East
By transasia bio-medicals ltd.
Transasia Bio-Medicals Ltd.- India's leading IVD Company adds another feather to its cap
By Biofortuna
Biofortuna, a UK based molecular diagnostics company with a proprietary stabilisation technology for molecular reagents, is expanding its custom service and manufacturing business with a £1.3m investment.

Page:
Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share